Arrowhead Pharmaceuticals Showcases Clinical Data at Major Industry Events
I'm PortAI, I can summarize articles.
Arrowhead Pharmaceuticals Inc. will participate in two major events in January 2026. They will host an Obesity KOL Webinar on January 6, 2026, focusing on ARO-INHBE and ARO-ALK7 interim clinical data. Additionally, they will present at the J.P. Morgan 2026 Healthcare Conference on January 12, 2026. This information was originally published by Arrowhead Pharmaceuticals via Business Wire.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments